Hong Cao
- Virology top 1%
- HIV Research and Treatment 22
- Hepatology top 2%
- Hepatitis C virus research 12
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 13
- Cancer Research top 5%
-
- Hepatitis B Virus Studies 19
- Liver Disease Diagnosis and Treatment 13
-
- interferon and immune responses 16
-
- Virus-based gene therapy research 14
-
- Pain Mechanisms and Treatments 13
- Co-authors
- Tariq M. RanaAkbar AliMuqi XuRobin NathansYongqiang WangCelia A. SchifferShijun J. ZhengJiayin Dai
- Journals
- Journal of the American Chemical Society (1 paper)Nucleic Acids Research (1 paper)Journal of Biological Chemistry (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Hong Cao
195 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 150
- Virology 713
- Hepatology 464
- Infectious Diseases 1.0k
- Cancer Research 588
- Health, Toxicology and Mutagenesis 454
Countries citing papers authored by Hong Cao
This map shows the geographic impact of Hong Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Cao more than expected).
Fields of papers citing papers by Hong Cao
This network shows the impact of papers produced by Hong Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Cao. The network helps show where Hong Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hong Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 15 | |
| 4 | 2021 | 49 | |
| 5 | 2020 | 29 | |
| 6 | 2020 | 3 | |
| 7 | 2020 | 25 | |
| 8 | 2019 | 28 | |
| 9 | 2019 | 11 | |
| 10 | 2018 | 18 | |
| 11 | A new anti-floatation method by drainage:concept and application | 2016 | 0 |
| 12 | 2015 | 1 | |
| 13 | 2015 | 92 | |
| 14 | 2013 | 16 | |
| 15 | [Comparative study on the clinical characteristics of HBV/HCV co-infection patients with different HCV contaminnation mode]. | 2011 | 2 |
| 16 | Effect and Safety of Radiofrequency Catheter Ablation for Single Small Hepatocellular Carcinoma | 2011 | 1 |
| 17 | 2010 | 93 | |
| 18 | 2010 | 100 | |
| 19 | Computer-based siRNA Design to Hepatitis B Virus and Its Expression Vector Construction | 2008 | 2 |
| 20 | Effect of curcumin on the expression of Bax and bcl-2 during cerebral ischemia in rat hippocampus | 2007 | 1 |
About Hong Cao
Hong Cao is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 205 papers that have together received 5.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (22 papers), Hepatitis B Virus Studies (19 papers), interferon and immune responses (16 papers), Virus-based gene therapy research (14 papers), HIV/AIDS drug development and treatment (13 papers), Liver Disease Diagnosis and Treatment (13 papers), Pain Mechanisms and Treatments (13 papers) and Hepatitis C virus research (12 papers). The work is most often cited by research in Virology (713 citations), Hepatology (464 citations) and Infectious Diseases (1.0k citations). Hong Cao has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Tariq M. Rana, Akbar Ali, Muqi Xu, Robin Nathans, Yongqiang Wang, Celia A. Schiffer, Shijun J. Zheng, Jiayin Dai, Chia‐Ying Chu and Xiaoqi Li. Their work appears in journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.